Main Article Content
Objective: To compare mean blood loss with Oxytocin plus Tranexamic acid versus Oxytocin alone in the prevention of postpartum hemorrhage.
Methodology: This randomized controlled trial was conducted in Department of Obstretrics & Gynaecology, Lady Reading Hospital, Peshawar on 400 women, distributed into two equal groups. Group A received 10 IU of I/V Oxytocin along with 1g of I/V tranexamic acid during the third stage of labor immediately after birth and Group B received 10 IU of I/V Oxytocin only immediately after birth. The incidence of postpartum hemorrhage was based on weighing dry and soaked pads using a digital weight machine and blood loss was measured. The drug was considered effective in terms of mean reduction of blood loss after 2 hours.
Results: Our study shows that in group A (Oxytocin plus Tranexamic acid), the mean age was 30±4.29 years whereas in group B (Oxytocin alone), the mean age was 31±4.71 years. In group A, mean blood loss was 30 ml± 6.02 whereas in group B, mean blood loss was 40 ml ± 7.88. The mean blood loss volume shows a significant difference in between the two groups with a p-value of 0.0001.
Conclusion: The study concludes a significant difference in mean blood loss volume after getting treatment for post-partum hemorrhage in both the treatment groups i.e Oxytocin plus Tranexamic (Gorup A) and Oxytocin alone (Group B). Furthermore, mean blood loss volume was much less in Group A as compared to Group B, illustrating effective treatment modality in Group A.
Work published in JPMI is licensed under a
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Pantoja T, Abalos E, Chapman E, Vera C, Serrano V. Oxytocin for prevent¬ing postpartum haemorrhage (PPH) in non-facility birth settings. Cochrane Database Syst Rev. 2016;4:CD011491. https://doi.org/10.1002/14651858. CD011491.pub2.
De Castro Parreira M, Gomes N. Pre¬venting postpartum haemorrhage: active management of the third stage of labour. J Clin Nurs. 2013;22(23- 24):3372-87. https://doi.org/10.1111/ jocn.12361.
Ali TS, Ather F. Prevalence of perceived heavy postpartum hemorrhage and its associated factors among married mothers in squatter settlements of Ka¬rachi. Khyber Med Uni J. 2013; 5(1):3- 8.
Kumar N, Pathak SS, Singh NK, Rudra S. Effectiveness of simulation tech¬nique in teaching-learning process for prevention of postpartum hemor¬rhage in obstetrics and gynecology. Int J Reprod Contracept Obstet Gy¬necol. 2016; 5(8): 2756-61. http:// dx.doi.org/10.18203/2320-1770.ijr¬cog20162661.
Faraoni D, Carlier C, Samama C, Levy J. Efficacy and safety of tranexamic acid administration for the prevention and/or the treatment of post-partum haemorrhage: A systematic review with meta-analysis. Annales Français¬esd’ Anesthésie et de Réanimation. 2014;33(11):563-71. https://doi. org/10.1016/j.annfar.2014.07.748.
Alam A, Choi S. Prophylactic use of tranexamic acid for postpartum bleeding outcomes: a systematic re-view and meta-analysis of random¬ized controlled trials. Transfus Med Rev. 2015;29(4):231-41. https://doi. org/10.1016/j.tmrv.2015.07.002
Novikova, N., Hofmeyr, G. and Cluver, C. Tranexamic acid for preventing post¬partum haemorrhage. Cochrane Da¬tabase Syst Rev. 2015;(6):CD007872. https://doi.org/10.1002/14651858. CD007872.pub3
Shakur H, Elbourne D, Gülmezoglu M, Alfirevic Z, Ronsmans C, Allen E, et al. The WOMAN Trial (World Maternal An¬tifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemor¬rhage: an international randomised, double blind placebo controlled tri¬al. Trials. 2010;11:40. https://doi. org/10.1186/1745-6215-11-40.
Sentilhes L, Lasocki S, Ducloy-Bouthors A, Deruelle P, Dreyfus M, Perroti F, et al. Tranexamic acid for the prevention and treatment of postpartum haemorrhage. Br J Anaesth. 2016;116(5):641-8. https://doi.org/10.1093/bja/aeu448.
Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T. Efficacy of tranexamic acid in reducing blood loss after ce¬sarean section. Int Society Perinatal Obstet. 2009;22(1):72-5. https://doi. org/10.1080/14767050802353580.
Barbieri RL, Sentilhes L. Advances in preventing postpartum hemorrhage. N Engl J Med. 2018: 1-8.
Xiong X, Buekens P, Alexander S, Demi-anczuk N, Wollast E. Anemia during pregnancy and birth out-come: A meta-analysis. Am J Perina¬tol. 2000;17(3):137-46. https://doi. org/10.1055/s-2000-9508
Xia Y, Griffiths, Xue BB, Sheng Q. Tranexamic acid for postpartum hemorrhage prevention in vag¬inal delivery. A meta-analysis. Medicine. 2020:99(3):e18792. h t t p s : / / d o i . o r g / 1 0 . 1 0 9 7 / md.0000000000018792.
Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H et al. High-dose tranexamic acid reduc¬es blood loss in postpartum haemor¬rhage. Critical Care. 2011;15(2):R117. https://doi.org/10.1186/cc10143.
Hawker L, Weeks A. Postpartum haem¬orrhage (PPH) rates in randomized trials of PPH prophylactic interventions and the effect of underlying participant PPH risk: a meta-analysis. BMC Pregnancy Childbirth. 2020;20(1):1-2. https://doi. org/10.1186/s12884-020-2719-3.
Atoyebi W, Mundy N, Croxton T, Little¬wood TJ, Murphy MF. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates? Br J Haematol. 2000;111(3):980-3.
Bonnar J. Massive obstetric haemor¬rhage. Baillieres Best Pract Res Clin Ob¬stet Gynaecol. 2000;14(1):1-18. https:// doi.org/10.1053/beog.1999.0060.
Lingam K, Hood V, Carty MJ. Angio¬graphic embolisation in the manage¬ment of pelvic haemorrhage. BJOG. 2000;107(9):1176-8. https://doi. org/10.1111/j.1471-0528.2000. tb11122.x.